Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ESR1 | P03372 | 9/20 | 1.00 |
| ▸ | ESR2 | Q92731 | 8/20 | 1.00 |
| ▸ | LMNA | P02545 | 4/20 | 1.00 |
| ▸ | MEN1 | O00255 | 3/20 | 1.00 |
| ▸ | MAPT | P10636 | 3/20 | 1.00 |
| ▸ | KMT2A | Q03164 | 3/20 | 1.00 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 1.00 |
| ▸ | GAA | P10253 | 2/20 | 1.00 |
| ▸ | G6PD | P11413 | 2/20 | 1.00 |
| ▸ | PKM | P14618 | 2/20 | 1.00 |
| ▸ | MAPK1 | P28482 | 2/20 | 1.00 |
| ▸ | MPI | P34949 | 1/20 | 1.00 |
| ▸ | CYP19A1 | P11511 | 4/20 | 0.80 |
| ▸ | STS | P08842 | 2/20 | 0.73 |
| ▸ | HSD17B10 | Q99714 | 3/20 | 0.66 |
| ▸ | TSHR | P16473 | 2/20 | 0.66 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.66 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.66 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.66 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.66 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29506781 | 1.00 | ESR1 (1.00) | ESR1ESR2LMNAMEN1MAPT | |
| SCHEMBL12027477 | 1.00 | ESR1 (1.00) | ESR1ESR2LMNAMEN1MAPT | |
| SCHEMBL224399 | 1.00 | ESR1 (1.00) | ESR1ESR2LMNAMEN1MAPT | |
| SCHEMBL13123059 | 1.00 | ESR1 (1.00) | ESR1ESR2LMNAMEN1MAPT | |
| SCHEMBL6009933 | 1.00 | ESR1 (1.00) | ESR1ESR2LMNAMEN1MAPT | |
| SCHEMBL11490000 | 0.90 | ESR1 (0.82) | ESR1ESR2LMNAMEN1MAPT | |
| SCHEMBL5526011 | 0.90 | ESR1 (0.82) | ESR1ESR2LMNAMEN1MAPT | |
| SCHEMBL5497284 | 0.90 | ESR1 (0.82) | ESR1ESR2LMNAMEN1MAPT | |
| SCHEMBL5497281 | 0.90 | ESR1 (0.82) | ESR1ESR2LMNAMEN1MAPT | |
| SCHEMBL5526013 | 0.90 | ESR1 (0.82) | ESR1ESR2LMNAMEN1MAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 561 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2025096781-A1 | METHODS AND COMPOSITIONS FOR PROVIDING CUSTOMIZED SKIN REGIMENS | VIBRANT HOLDINGS, LLC (US) | 2025-05-08 | — | — | WO | claimed |
| US-20240093191-A1 | COMPOSITIONS AND METHODS FOR TREATING DISEASE ASSOCIATED WITH DUX4 OVEREXPRESSION | RESEARCH INSTITUTE AT NATIONWIDE CHILDREN'S HOSPITAL (US) | 2024-03-21 | — | — | US | claimed |
| EP-4288539-A1 | COMPOSITIONS AND METHODS FOR TREATING DISEASE ASSOCIATED WITH DUX4 OVEREXPRESSION | Research Institute at Nationwide Children's Hospital (US) | 2023-12-13 | — | — | EP | claimed |
| WO-2022169922-A1 | COMPOSITIONS AND METHODS FOR TREATING DISEASE ASSOCIATED WITH DUX4 OVEREXPRESSION | RESEARCH INSTITUTE AT NATIONWIDE CHILDREN'S HOSPITAL (US) | 2022-08-11 | — | — | WO | claimed |
| WO-2022082183-A1 | COMPOUNDS AND METHODS FOR THE TREATMENT OF INFLAMMATORY AND METABOLIC DISEASES | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2022-04-21 | — | — | WO | claimed |
| US-20210379087-A1 | COMPOSITIONS FOR THE ELIMINATION OF SENESCENT CELLS | MEDIZINISCHE UNIVERSITÄT WIEN (AT) | 2021-12-09 | — | — | US | claimed |
| CN-113347969-A | Composition for eliminating senescent cells | 维也纳自然资源与生命科学大学 | 2021-09-03 | — | — | CN | claimed |
| EP-3643305-A1 | COMPOSITIONS FOR THE ELIMINATION OF SENESCENT CELLS | Universität für Bodenkultur Wien (AT) | 2020-04-29 | — | — | EP | claimed |
| CN-110596254-A | Kit for detecting estrogen and/or active metabolite thereof and application thereof | 徐州医科大学 | 2019-12-20 | — | — | CN | claimed |
| CN-106353514-B | A kind of system for assessing individual sex hormone metabolism state | 南京精全生物医药科技有限公司 | 2019-08-13 | — | — | CN | claimed |
| WO-2003092585-A2 | CONTROLLED RELEASE COMPOSITIONS OF ESTRADIOL METABOLITES | PR PHARMACEUTICALS, INC. (US) | 2003-11-13 | — | — | WO | claimed |
| WO-2003081208-A2 | IMPROVEMENTS IN PHARMACEUTICAL DISCOVERY AND DEVELOPMENT | ESA, INC. (US) | 2003-10-02 | — | — | WO | claimed |
| US-20030050294-A1 | Administration of estradiol metabolites for the treatment or prevention of obesity, metabolic syndrome, diabetes, and vascular and renal disorders | PITTSBURGH, UNIVERSITY OF | 2003-03-13 | — | — | US | claimed |
| WO-2003015704-A2 | ADMINISTRATION OF ESTRADIOL METABOLITES FOR THE TREATMENT OR PREVENTION OF OBESITY, METABOLIC SYNDROME, DIABETES, AND VASCULAR AND RENAL DISORDERS | UNIVERSITY OF PITTSBURGH (US) | 2003-02-27 | — | — | WO | claimed |
| EP-1206480-A2 | METHODS OF OBTAINING 2-METHOXYESTRADIOL OF HIGH PURITY | EntreMed, Inc. (US) | 2002-05-22 | — | — | EP | claimed |
| US-20020019057-A1 | Ferrocenyl boronate derivatization of chemical compounds undergoing mass spectrometry analysis | NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT | 2002-02-14 | — | — | US | claimed |
| WO-2001014405-A2 | METHODS OF OBTAINING 2-METHOXYESTRADIOL OF HIGH PURITY | ENTREMED, INC. (US) | 2001-03-01 | — | — | WO | claimed |
| WO-1997040061-A1 | ESTROGEN-PURINE BASE, ESTROGEN-MERCAPTURATE ADDUCTS, AND FLUORESCENT PROBES AND MONOCLONAL ANTIBODIES THEREOF | BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA (US) | 1997-10-30 | — | — | WO | claimed |
| US-4937238-A | ADMINISTERING ESTROGEN COMPOUNDS | THE BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA (US) | 1990-06-26 | — | — | US | claimed |
| US-4427669-A | 2-HYDROXY-OR 4-HYDROXYESTRADIOL | THE BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA (US) | 1984-01-24 | — | — | US | claimed |